Table 3 Results of multivariable regression models for the SLE group—dependent variable: pRNFL thickness
Model | Coefficient estimate | 95% confidence interval | p-value |
|---|---|---|---|
Dependent variable: pRNFL thickness G | |||
Age (years) | − 3.02 | − 4.91 to − 1.13 | 0.002 |
Axial length (mm) | − 3.98 | − 6.34 to − 1.62 | 0.001 |
Calcium channel blocker | − 10.66 | − 18.56 to − 2.77 | 0.009 |
Anticoagulant | − 6.71 | − 12.42 to − 1.00 | 0.022 |
Dependent variable: pRNFL thickness TS | |||
Age (years) | − 3.38 | − 6.55 to − 0.22 | 0.037 |
Axial length (mm) | − 4.12 | − 8.13 to − 0.12 | 0.044 |
Dependent variable: pRNFL thickness T | |||
Sjogren syndrome | − 10.36 | − 19.38 to − 1.35 | 0.025 |
Dependent variable: pRNFL thickness TI | |||
IOP (mm Hg) | − 2.15 | − 3.60 to − 0.71 | 0.004 |
Calcium channel blocker | − 17.97 | − 32.64 to − 3.30 | 0.017 |
Anticoagulant | − 15.08 | − 25.84 to − 4.31 | 0.007 |
Statin | − 13.94 | − 25.73 to − 2.15 | 0.021 |
Dependent variable: pRNFL thickness NI | |||
Axial length (mm) | − 9.03 | − 14.59 to − 3.47 | 0.002 |
Anticoagulant | − 17.16 | − 31.56 to − 2.76 | 0.020 |
Statin | − 18.56 | − 34.09 to − 3.03 | 0.020 |
Dependent variable: pRNFL thickness N | |||
Body mass index (kg/m2) | − 0.80 | − 1.58 to − 0.01 | 0.046 |
ACE inhibitor | − 10.03 | − 18.61 to − 1.45 | 0.023 |
Dependent variable: pRNFL thickness NS | |||
Axial length (mm) | − 5.47 | − 9.46 to − 1.47 | 0.008 |
Calcium channel blocker | − 20.07 | − 34.01 to − 6.12 | 0.006 |
Anticoagulant | − 11.34 | − 21.99 to − 0.69 | 0.037 |
Corticosteroid (mg) | 0.12 | 0.05 to 0.18 | 0.001 |